Schultz et al., 2013 - Google Patents
An Increasing Role for 68Ga PET Imaging: A Perspective on the Availability of Parent 68Ge Material for Generator Manufacturing in an Expanding MarketSchultz et al., 2013
View PDF- Document ID
- 1592578395649536035
- Author
- Schultz M
- Donahue P
- Musgrave N
- Zhernosekov K
- Naidoo C
- Razbash A
- Tworovska I
- Dick D
- Watkins G
- Graham M
- Runde W
- Clanton J
- Sunderland J
- Publication year
- Publication venue
- Postgraduate Medicine Education and Research
External Links
Snippet
The use of gallium-68 for molecular imaging is gaining momentum world-wide. While our understanding of 68Ga chemistry, generators, and associated synthesis modules appear to have advanced to a clinically-reliable stage, uncertainty in the supply of …
- 238000004519 manufacturing process 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mikolajczak et al. | Radiometals for imaging and theranostics, current production, and future perspectives | |
| Argyrou et al. | Rhenium‐188 Production in Hospitals, by W‐188/Re‐188 Generator, for Easy Use in Radionuclide Therapy | |
| Misiak et al. | 47 Sc production development by cyclotron irradiation of 48 Ca | |
| Boschi et al. | Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons | |
| Decristoforo et al. | Feasibility and availability of 68 Ga-labelled peptides | |
| Boschi et al. | 188W/188Re generator system and its therapeutic applications | |
| Rösch | 68Ge/68Ga generators: past, present, and future | |
| Decristoforo | Gallium-68–A New Opportunity For PET Available From a Long Shelflife Generator–Automation and Applications | |
| Jalilian et al. | IAEA activities on 67Cu, 186Re, 47Sc theranostic radionuclides and radiopharmaceuticals | |
| Krijger et al. | The necessity of nuclear reactors for targeted radionuclide therapies | |
| Choiński et al. | Prospects for the production of radioisotopes and radiobioconjugates for theranostics | |
| Willowson | Production of radionuclides for clinical nuclear medicine | |
| Dash et al. | Electrochemical separation: promises, opportunities, and challenges to develop next-generation radionuclide generators to meet clinical demands | |
| JP2017518492A (en) | Production of 43Sc radionuclide and its radiopharmaceutical for use in positron emission tomography | |
| Debnath et al. | Radiopharmaceuticals and their therapeutic applications in health care system | |
| Schultz et al. | An Increasing Role for 68Ga PET Imaging: A Perspective on the Availability of Parent 68Ge Material for Generator Manufacturing in an Expanding Market | |
| Brown | Metal oxide sorbents for the separation of radium and actinium | |
| Knapp et al. | Re-emergence of the important role of radionuclide generators to provide diagnostic and therapeutic radionuclides to meet future research and clinical demands | |
| Türler | Matched Pair Theranostics: Medicinal Chemistry and Chemical Biology Highlights | |
| Maiti | Nuclear and chemical data for life sciences | |
| O'Brien | Utilization of an intense beam of 800 MeV protons to prepare radionuclides | |
| Faintuch et al. | Complexation of 188Re-phosphonates: in vitro and in vivo studies | |
| Albander et al. | New trends in preparation, bio distribution, and pharmacokinetics of radiopharmaceuticals in diagnosis and research | |
| Martini | High-Yield Cyclotron Production of Metallic Radioisotopes for Nuclear Medicine | |
| Knapp Jr | The development and use of radionuclide generators in nuclear medicine. Recent advances and future perspectives |